Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001

Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001

Neuroendocrine tumors (NETs) are grouped together as a single class on the basis of histologic appearance, immunoreactivity for the neuroendocrine markers chromogranin A and synaptophysin, and potential secretion of hormones, neurotransmitters, neuromodulators and neuropeptides. Nevertheless, despit...

Full description

Bibliographic Details
Main Authors: Corey A. Carter, Bruno Schmitz, P. Gabriel Peterson, Mary Quinn, Aiste Degesys, John Jenkins, Bryan Oronsky, Jan Scicinski, Scott Caroen, Tony R. Reid, Pedro Cabrales, Christina Brzezniak
Format: Article
Language:English
Published: Karger Publishers 2016-03-01
Series:Case Reports in Oncology
Subjects:
Neuroendocrine tumor
Immune reactivity
Pseudoprogression
Serial biopsy
RRx-001
Tumor flare
Online Access:http://www.karger.com/Article/FullText/444633

Internet

http://www.karger.com/Article/FullText/444633

Similar Items